Cargando…

Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy

Immunotherapy has emerged as a promising strategy for cancer treatment, in which durable immune responses were generated in patients with malignant tumors. In the past decade, biomaterials have played vital roles as smart drug delivery systems for cancer immunotherapy to achieve both enhanced therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Rongwei, Wu, Qiang, Wang, Jing, Zheng, Xiaoming, Ou, Rongying, Xu, Yunsheng, Qu, Shuxin, Li, Danyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334721/
https://www.ncbi.nlm.nih.gov/pubmed/34368109
http://dx.doi.org/10.3389/fbioe.2021.723490
_version_ 1783733071168667648
author Cui, Rongwei
Wu, Qiang
Wang, Jing
Zheng, Xiaoming
Ou, Rongying
Xu, Yunsheng
Qu, Shuxin
Li, Danyang
author_facet Cui, Rongwei
Wu, Qiang
Wang, Jing
Zheng, Xiaoming
Ou, Rongying
Xu, Yunsheng
Qu, Shuxin
Li, Danyang
author_sort Cui, Rongwei
collection PubMed
description Immunotherapy has emerged as a promising strategy for cancer treatment, in which durable immune responses were generated in patients with malignant tumors. In the past decade, biomaterials have played vital roles as smart drug delivery systems for cancer immunotherapy to achieve both enhanced therapeutic benefits and reduced side effects. Hydrogels as one of the most biocompatible and versatile biomaterials have been widely applied in localized drug delivery systems due to their unique properties, such as loadable, implantable, injectable, degradable and stimulus responsible. Herein, we have briefly summarized the recent advances on hydrogel-by-design delivery systems including the design of hydrogels and their applications for delivering of immunomodulatory molecules (e.g., cytokine, adjuvant, checkpoint inhibitor, antigen), immune cells and environmental regulatory substances in cancer immunotherapy. We have also discussed the challenges and future perspectives of hydrogels in the development of cancer immunotherapy for precision medicine at the end.
format Online
Article
Text
id pubmed-8334721
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83347212021-08-05 Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy Cui, Rongwei Wu, Qiang Wang, Jing Zheng, Xiaoming Ou, Rongying Xu, Yunsheng Qu, Shuxin Li, Danyang Front Bioeng Biotechnol Bioengineering and Biotechnology Immunotherapy has emerged as a promising strategy for cancer treatment, in which durable immune responses were generated in patients with malignant tumors. In the past decade, biomaterials have played vital roles as smart drug delivery systems for cancer immunotherapy to achieve both enhanced therapeutic benefits and reduced side effects. Hydrogels as one of the most biocompatible and versatile biomaterials have been widely applied in localized drug delivery systems due to their unique properties, such as loadable, implantable, injectable, degradable and stimulus responsible. Herein, we have briefly summarized the recent advances on hydrogel-by-design delivery systems including the design of hydrogels and their applications for delivering of immunomodulatory molecules (e.g., cytokine, adjuvant, checkpoint inhibitor, antigen), immune cells and environmental regulatory substances in cancer immunotherapy. We have also discussed the challenges and future perspectives of hydrogels in the development of cancer immunotherapy for precision medicine at the end. Frontiers Media S.A. 2021-07-21 /pmc/articles/PMC8334721/ /pubmed/34368109 http://dx.doi.org/10.3389/fbioe.2021.723490 Text en Copyright © 2021 Cui, Wu, Wang, Zheng, Ou, Xu, Qu and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Cui, Rongwei
Wu, Qiang
Wang, Jing
Zheng, Xiaoming
Ou, Rongying
Xu, Yunsheng
Qu, Shuxin
Li, Danyang
Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy
title Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy
title_full Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy
title_fullStr Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy
title_full_unstemmed Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy
title_short Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy
title_sort hydrogel-by-design: smart delivery system for cancer immunotherapy
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334721/
https://www.ncbi.nlm.nih.gov/pubmed/34368109
http://dx.doi.org/10.3389/fbioe.2021.723490
work_keys_str_mv AT cuirongwei hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy
AT wuqiang hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy
AT wangjing hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy
AT zhengxiaoming hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy
AT ourongying hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy
AT xuyunsheng hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy
AT qushuxin hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy
AT lidanyang hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy